6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
26m ago	Nayax to Report 2026 Q1 Earnings on May 12, 2026
53m ago	CC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
1h ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
1h ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
1h ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine

About

Diamedica Therapeutics Inc (NASDAQ:DMAC) — investor relations, events, news, and company updates on 6ix.

Latest News

DiaMedica Therapeutics Reports Full Year 2025 Financial Results and Provides Business Highlights

DiaMedica Therapeutics to Report Fourth Quarter 2025 Financial Results and Provide a Business Update March 31, 2026

DiaMedica Therapeutics Receives Health Canada Clearance to Initiate Phase 2 Study of DM199 in Preeclampsia

DiaMedica Therapeutics to Participate in Upcoming March Investor Conferences

DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Financials

Revenue

$0

Market Cap

$349.16 M

EPS

-0.70

Community Chat

Ask AI